热门资讯> 正文

Zymeworks宣布关键管理变革

2026-01-12 20:32

Zymeworks Inc.(ZYME) 0

Clinical-stage biotechnology company Zymeworks (ZYME) said that Dr. Sabeen Mekan has been promoted to senior VP and chief medical officer, effective February 1, 2026.
Dr. Jeff Smith, current CMO, will be retiring effective January 31, 2026, while continuing to provide services as an adviser for a transitional time period.
Besides, Mr. Mark Hollywood has been promoted to executive VP and COO with expanded responsibilities.

More on Zymeworks

HERIZON-GEA-01 Trial Highlights Zymeworks' Path To $440M Milestones And Growth
Zymeworks Inc. (ZYME) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Zymeworks: Adjusting My Levels After Ziihera's Phase III Data For GEA
Zymeworks reports positive phase 3 Ziihera data; cash runway extended beyond 2028
Zymeworks shifts to a royalty-driven business model

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。